Related U.S. Application Data 2 страница

US 9, 539, 210 B2

Page 4

(56)

References Cited

PATENT DOCUMENTS

FOREIGN PATENT DOCUMENTS

US 9, 539, 210 B2

Page 5

References Cited

FOREIGN PATENT DOCUMENTS

OTHER PUBLICATIONS

Ackermand & Cresswell, “Cellular mechanisms governing cross­presentation of exogenous antigens”, Nat. Immunol., 5(7): 678-684 (2004).

Aime, et al., “Lanthanide(III) chelates for NMR biomedical appli­cations”, Chemical Society Reviews, 27: 19-29 (1998).

Akagi, et al., “Development of vaccine adjuvants using polymeric nanoparticles and their potential applications for anti-HIV vaccine”, Yakugaku Zasshi, 127(2): 307-17 (2007) English Abstract.

Akagi, et al., “Multifunctional conjugation of proteins on/into bio-nanoparticles prepared by amphiphilic poly(gamma-glutamic acid)”, J Biomat Sci Polym Ed., 17(8): 875-92 (2006).

Akaishi, et al., “Targeting chemotherapy using antibody-combined liposome against human pancreatic cancer cell-line. ”, The Tohoku Journal of Experimental Medicine, 175(l): 29-42 (1995).

Allen, et al., “Nano-engineering block copolymer aggregates for drug delivery. ”, Colloids Surfaces B-Biointerfaces, 16: 3-27 (1999). Allison, et al., “The mode of action of immunological adjuvants. ”, Dev. Biol. Stand., 92: 3-11 (1998).

Altschul, et al., “Basic local alignment search tool. ”, J. Mol Biol., 2I5(3): 403-I0 (1990).

Altschul, et al., “Gapped BLAST and PSI-BLAST: a new genera­tion of protein database search programs. ”, Nucleic Acids Res., 25(I7): 3389-3402 (1997).

Angelucci, et al., “Neuroendocrine transdifferentiation induced by VPA is mediated by PPAR³ activation and confers resistance to antiblastic therapy in prostate carcinoma”, The Prostate, 68(6): 588- 598 (2008).

Argov-Argaman, et al., “Lactosomes: Structural and compositional classification of unique nanometer-sized protein lipid particles of human milk”, J Agric Food Chem., 58: 11234-42 (2010).

Astete and Sabliov, “Synthesis and characterization of PLGA nanoparticles”, J. Biomat. Sci., -Polymer Ed., 17: 247-289 (2006).

Atkinson, et al., “Conjugation of folate via gelonin carbohydrate residues retains ribosomal-inactivating properties of the toxin and permits targeting to folate receptor positive cells. ”, J. Biol. Chem., 276(30): 27930-27935 (2001).

Avgoustakis, “Pegylated poly(lactide) and poly(lactide-co- glycolide) nanoparticles: preparation, properties and possible appli­cations in drug delivery”, Curr Drug Deliv., 1: 321-33 (2004). Baba, et al., “Human neutralizing monoclonal antibodies of the IgGl subtype protect against mucosal simian-human immunodefi­ciency virus infection. ”, Nat. Med., 6(2): 200-206 (2000).

Babaian, et al., “Radioimmunological imaging of metastatic prostatic cancer with lllindium-labeled monoclonal antibody PAY 276. ”, J. Urol., 137(3): 439-443 (1987).

Bachmann, et al., “T helper cell-independent neutralizing В cell response against vesicular stomatitis virus: role of antigen patterns in В cell induction? ”, Eur. J. Immunol., 25(12): 3445-3451 (1995). Bagalkot, et al., “An Aptamer-Doxorubicin Physical Conjugate as a Novel Targeted Drug-Delivery Platform”, Angew. Chem. Int. Ed., 45(48): 8149-8152 (2006).

Bander, et al., “Targeting metastatic prostate cancer with radiolabeled monoclonal antibody J591 to the extracellular domain ofprostate specific membrane antigen. ”, J. Urol., 170(5): 1717-1721 (2003).

Barchet, et al., “Virus-induced interferon alpha production by a dendritic cell subset in the absence of feedback signaling in vivo. ”, J. Exp. Med., 195(4): 507-516 (2002).

Barrera, et al., “Synthesis and RGD peptide modification of a new biodegradable copolymer: poly(lactic acid-co-lysine)”, J. Am. Chem. Soc., 115(23): 11010-11011 (1993).

Bauer, et al., “SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. ”, Life Sci., 31(11): 1133-1140 (1982).

Beaureparie, et al., “Functionalized Fluorescent Oxide Nanoparticles: Artificial Toxins for Sodium Channel Targeting and Imaging at the Single-Molecule Level”, Nano Letters, 4(11): 2079- 2083 (2004).

Bennett, et al., “Inhibition of the Aminopeptidase from Aeromonas Proteolytica by I-Leucinephosphonic Acid, a Transition State Ana­logue of Peptide Hydrolysis”, J. Am. Chem. Soc., 120(46): 12139­12140 (1998).

Bies et al., Lectin-medicated drug targeting: history and applica- tions\, Advanced Drug Delivery Reviews, 56: 425-435 (2004).

Binetruy-Tournaire, et al., “Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis. ”, EMBO J., 19(7): 1525-1533 (2000).

Bjerke, et al., “Comparison of monoclonal and polyclonal antibod­ies to continine in nonisotopic and isotopic immunoassays”, J. Immunol. Meth., 96: 239-246 (1987).

Восса, et al., “Phagocytic uptake of fluorescent slealth solid lipid nanoparticles”, Int. J. Pharmaceutics, 175: 185-193 (1998).

Boes, et al., “T-cell engagement of dendritic cells rapidly rearranges MHC class II transport. ”, Nature, 418(6901): 983-988 (2002).

Bonifaz, et al., “Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presen­tation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. ”, J. Exp. Med., 196(12): 1627­1638 (2002).

Bottausci, et al., “Mixing in the shear superposition micromixer: three-dimensional analysis”, Philosophical Transactions of the Royal Society of London Series a—Mathematical Physical and Engineering Sciences, 362: 1001-1018 (2004).

Boussif, et al., “A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. ”, Proc. Natl. Acad. Sci., USA, 1995, 92: 7297-7301 (1995).

Bozzacco, et al., “DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human МНС I haplotypes. ”, Proc. Natl. Acad. Sci., USA, 104(4): 1289-1294 (2007).

Brito, et al., “Nanoparticulate carriers for the treatment of coronary restenosis. ”, Int J Nanomedicine, 2(2): 143-161 (2007).

Brooking et al., “Transport of Nanoparticles Across the Rat Nasal Mucosa”, Journal of Drug Targeting, 9(4): 267-279 (2001).

Burmeister, et al., “Direct in vitro selection of a 2'-O-methyl aptamer to VEGF”, Chem Biol, 12(l): 25-33 (2005).

Carino, et al., “Nanosphere based oral insulin delivery, ” J. Control. Release, 65(l-2): 261-9 (2000).

Casola, et al., “B cell receptor signal strength determines В cell fate. ”, Nat. Immunol., 5(3): 317-327 (2004).

Castro, et al., “Nicotine Antibodies: Comparison of Ligand Speci­ficities of Antibodies Produced against Two Nicotine Conjugates”, Eur. J. Biochem., 104: 331-340 (1980).

Castro & Prieto, “Nicotine Antibody Production: Comparison of two nicotine conjugates in different animal species”, Biochem. Biophys. Res. Comm., 67(2): 583-589 (1975).

Cerchia, et al. “Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase”, PLoS Biology, 3(4): 849- 60 (2005).

Chacon, et al., “Optimized preparation of poly D, L (lactic-glycolic) microspheres and nanoparticles for oral administration”, Int’l J. Pharmaceutics, 141: 81-91 (1996).

Chaires, et al., “Preferential binding of daunomycin to 5'ATCG and 5'ATGC sequences revealed by footprinting titration experiments. ”, Biochemistry, 29(26): 6145-6153 (1990).

Chandy, et al., “5-Fluorouracil-loaded chitosan coated polylactic acid pmicrospheres as biodegradable drug carriers for cerebral tumors”, J. Microencapsulation, 17(5): 625-638 (2000).

US 9, 539, 210 B2

Page 6

(56)                     References Cited

OTHER PUBLICATIONS

Chandy et al., “Development of Poly(Lactic Acid)/Chitosan Co­Matrix Microspheres: Controlled Release of Taxol-Heparin for Preventing Restenosis”, Drug Delivery, 8: 77-86 (2001).

Chang, et al., “Five Different Anti-Prostate-specific Membrane Antigen (PSMA) Antibodies Confirm PSMA Expression in Tumor- associated Neovasculature”, Cancer Res., 59: 3192-3198 (1999).

Cheng, et al., “Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. ”, Biomaterials, 28(5): 869-876 (2007).

Christian, et al., “Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels. ”, J. Cell Biol., 163(4): 871-878 (2003).

Chu, et al, “Aptamer: toxin conjugates that specifically target pros­tate tumor cells”, Cancer Res., 66: 5989-92 (2006).

Chu, et al., “Aptamer mediated siRNA delivery”, Nuc. Acid Res., 34: e73 (2006).

Chu, et al., “Labeling tumor cells with fluorescent nanocrystal­aptamer bioconjugates. ”, Biosens. Bioelectron., 21: 1859-1866 (2006).

Clark, “The reticulum of lymph nodes in mice studied with the electron microscope. ”, Am. J. Anat., 110: 217-257 (1962).

Connor, et al., “Ex vivo evaluation of anti-EpCAM immunocytokine huKS-IL2 in ovarian cancer. ”, J. Immunother., 27(3): 211-219 (2004).

Coppi, et al., “Chitosan-Alginate Microparticles as a Protein Car­rier”, Drug Development and Industrial Pharmacy, 27(5): 393-400 (2001).

Croy and Kwon, “Polymeric micells for drug delivery”, Curr. Pharm. Design, 12: 4669-4684 (2006).

Dang and Rock, “Stimulation of В lymphocytes through surface Ig receptors induces LFA-1 and ICAM-1-dependent adhesion. ”, J. Immunol., 146(10): 3273-3279 (1991).

De Graaf, et al., “A fully human anti-Ep-CAM scFv-beta- glucuronidase fusion protein for selective chemotherapy with a glucuronide prodrug. ”, Br. J. Cancer, 86(5): 811-818 (2002).

De Jaeghere, et al., “Freeze-drying and lyopreservation of diblock and triblock poly(lactic acid)-poly(ethylene oxide) (PLA-PEO) copolymer nanoparticles. ”, Pharm. Dev. Technol., 5(4): 473-483 (2000).

Delemarre, et al., “Repopulation of macrophages in popliteal lymph nodes of mice after liposome-mediated depletion. ”, J. Leukoc. Biol., 47(3): 251-257 (1990).

Demello, “Control and detection of chemical reactions in microfluidic systems. ”, Nature, 442(7101): 394-402 (2006).

Demello and Demello, “Microscale reactors: nanoscale products. ”, Lab on a Chip, 4(2): 11N-15N (2004).

Deming, et al., “Facile synthesis of block copolypeptides of defined architecture. ”, Nature, 390(6658): 386-389 (1997).

Derfus, et al., “Intracellular Delivery of Quantum Dots for Live Cell Labeling and Organelle Tracking”, Advanced Materials, 16: 961­966 (2004).

Dimarco and Arcamone, “DNA complexing antibiotics: Daunomycin, adriamycin and their derivates. ”, Arzneim-Forsch. (Drug Res. ), 25: 368-375 (1975).

Ding, et al., “Syntheses of conformationally constricted molecules as potential NAALADase/PSMA inhibitors. ”, Org. Lett., 6(11): 1805-1808 (2004).

Dinkla, et al., “Identification of a streptococcal octapeptide motif involved in acute rheumatic fever. ”, J. Biol. Chem., 282(26): 18686­18693 (2007).

Dykxhoorn, et al., “Killing the messenger: short RNAs that silence gene expression. ”, Nat. Rev. Mol. Cell Biol., 4(6): 457-467 (2003). D\Antonio, et al., “Longitudinal analysis of androgen deprivation of prostate cancer cells identifies pathways to androgen indepen­dence”, The Prostate, 68(7): 698-714 (2008).

Eklund, et al., “Denileukin diftitox: a concise clinical review. ”, Expert Rev. Anticancer Ther., 5(l): 33-38 (2005).

Elamanchili, et al., “Pathogen-mimicking nanoparticles for vaccine delivery to dendritic cells”, J Cont. Rel., 30(4): 378-95 (2007).

Elbashir, et al., “RNA interference is mediated by 21- and 22-nucleotide RNAs. ”, Genes Dev., 15(2): 188-200 (2001).

Eldridge, et al., “Biodegradable microspheres as a vaccine delivery system, ” Mol. Immunol., 28(3): 287-94 (1991).

Elsasser-Beile, et al., “Anew generation of monoclonal and recom­binant antibodies against cell-adherent prostate specific membrane antigen for diagnostic and therapeutic targeting of prostate cancer. ”, Prostate, 66(13): 1359-1370 (2006).

Elvassore, et al., “Production iof Insulin-Loaded Poly(Ethylene Glycol)/Poly(I-Lactide) (PEG/PLA) Nanoparticles by Gas Antisolvent Techniques”, Journal of Pharmacrutical Sciences, 90(10): 1628-36 (2001).

Ermak and Giannasca, “Microparticle targeting to M cells”, Advanced Drug Delivery Reviews, 34: 261-283 (1998).

Farokhazad, et al., “Nanoparticle-Aptamer Bioconjugates: A New Approach for Targeting Prostate Cancer Cells, ” Cancer Research, 64: 7668-7672 (2004).

Farokhzad, et al., “Nanoparticle-aptamer bioconjugates for cancer targeting”, Expert Opin. Drug Delivery, 3(3): 311-324 (2006).

Farokhzad, et al., “Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. ”, Proc. Natl. Acad. ScL, USA, 103(16): 6315-6320 (2006).

Farr, et al., “The structure of the sinus wall of the lymph node relative to its endocytic properties and transmural cell passage. ”, Am. J. Anat., 157(3): 265-284 (1980).

Fire, et al., “Potent and specific genetic interference by double­stranded RNA in Caenorhabditis elegans. ”, Nature, 391(6669): 806- 811 (1998).

Fi Li Povic-Grcic et al., “Mucoadhesive chitosan-coated liposomes: characteristics and stability”, J. Microencapsulation, 18 1: 3-12 (2001).

Fonseca, et al., “Paclitaxel-loaded PLGA nanoparticles: prepara­tion, physicochemical characterization and in vitro anti-tumoral activity. ”, J. Control. Release, 83(2): 273-286 (2002).

Foss, et al., “Radiolabeled small-molecule ligands for prostate­specific membrane antigen: in vivo imaging in experimental models of prostate cancer”, Clin. Cancer Res., 11: 4022-28 (2005).

Fracasso, et al., “Anti-tumor effects of toxins targeted to the prostate specific membrane antigen. ”, Prostate, 53(l): 9-23 (2002).

Francis, et al., “A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumours. ”, Br. J. Cancer, 87(6): 600-607 (2002).

Frankel, et al., “Phase I trial of a novel diphtheria toxin/granulocyte macrophage colony-stimulating factor fusion protein (DT388GMCSF) for refractory or relapsed acute myeloid leukemia. ”, Clin. Cancer Res., 8(5): 1004-1013 (2002).

Frederick, et al., “Structural comparison of anticancer drug-DNA complexes:        adriamycin and daunomycin. ”, Biochemistry,

29(10): 2538-2549 (1990).

Froidevaux, et al., “Somatostatin analogs and radiopeptides in cancer therapy. ”, Biopolymers, 66(3): 161-183 (2002).

Fujita, et al., “Cytokine profiling of prostatic fluid from cancerous prostate glands identifies cytokines associated with extent of tumor and inflammation”, The Prostate, 68(8): 872-882 (2008).

Gao, et al., “A method for the generation of combinatorial antibody libraries using pIX phage display, ” Proc. Natl. Acad. Sci. U. S. A., 99(20): 12612-6 (2002).

Gao, et al., “In vivo cancer targeting and imaging with semicon­ductor quantum dots. ”, Nat. Biotechnol., 22(8): 969-976 (2004).

Gao, et al., “In vivo molecular and cellular imaging with quantum dots. ”, Curr. Op. Biotechnol., 16: 63-72 (2005).

Gaserod et al., “The enhancement of the bioadhesive properties of calcium alginate gel beads by coating with chitosan”, Inti. J. of Pharmaceutics, 175: 237-246 (1998).

Gershlick, “Treating atherosclerosis: local drug delivery from labo­ratory studies to clinical trials, ” Atherosclerosis, 160(2): 259-71 (2002).

Gillies, et al., “An anti-CD20-IL-2 immunocytokine is highly efficacious in a SCID mouse model of established human В lym­phoma. ”, Blood, 105(10): 3972-3978 (2005).

US 9, 539, 210 B2

Page 7

(56)                     References Cited

OTHER PUBLICATIONS

Gorelik, et al., “Scanning surface confocal microscopy for simul­taneous topographical and fluorescence imaging: application to single virus-like particle entry into a cell”, PNAS, 99(25): 16018-23 (2002).

Govender, et al., “Defining the drug incorporation properties of PLA-PEG nanoparticles”, Inti J of Pharmaceutics, 1999: 95- 110(2000).

Grauer, et al., “Identification, purification, and subcellular localiza­tion of prostate-specific membrane antigen PSM’ protein in the LNCaP prostatic carcinoma cell line. ”, Cancer Res., 58(21): 4787- 4789 (1998).

Gref, et al., “Biodegradable long-circulating polymeric nanospheres. ”, Science, 263(5153): 1600-1603 (1994).

Haensler, et al., “Polyamidoamine cascade polymers mediate effi­cient transfection of cells in culture”, Bioconjugate Chem., 4(5): 372-379 (1993).

Haj, et al., “New findings in the study on the intercalation of bisdaunorubicin and its monomeric analogues with naked and nucleus DNA ”, Chem. Biol. Interact., 145(3): 349-358 (2003). Hallahanm, et al., “Integrin-mediated targeting of drug delivery to irradiated tumor blood vessels”, Cancer Cell, 3: 63-74 (2003).

Hanes, et al., “Polymer microspheres for vaccine delivery. ”, Pharm. Biotechnol., 6: 389-412 (1995).

Hangartner, et al., “Antiviral immune responses in gene-targeted mice expressing the immunoglobulin heavy chain of virus-neutral­izing antibodies. ”, Proc. Natl. Acad. Sci., USA, 100: 12883-12888 (2003).

Hannon, et al., “Unlocking the potential of the human genome with RNA interference”, Nature, 431(7006): 371-378 (2004).

Harada and Kataoka, “Supramolecular assemblies of block copo­lymers in aqueous media as nanocontainers relevant to biological applications”, Progress Polymer Sci., 31(ll): 949-982 (2006).

Harper, et al., “Efficacy of a bivalent LI virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. ”, Lancet, 364(9447): 1757-1765 (2004).

Harris, et al., “Proteolytic actuation о nanoparticle self-assembly”, Angewandte Chemie, 118: 3233-7 (2006).

Haseloff and Gerlach, “Simple RNA enzymes with new and highly specific endoribonuclease activities. ”, Nature, 334(6183): 585-591 (1988).

Hawiger, et al., “Dendritic cells induce peripheral T cell unrespon­siveness under steady state conditions in vivo. ”, J. Exp. Med. 194(6): 769-779 (2001).

He, et al., “A microRNA polycistron as a potential human onco­gene, ” Nature, 435(7043): 828-833 (2005).

Heald, et al., “Poly(lactic acid)-poly(ethylene oxide) (PLA-PEG) nanoparticles: NMR studies of the central solidlike PLA core and the liquid PEG corona”, Langmuir, 18: 3669-3675 (2002).

Hejazi et al., “Stomach-specific anti-H. pylon therapy. I: prepara­tion and characterization of tetracyline-loaded chitosan microshpheres”, Inti. J. of Pharmaceutics, 235: 87-94 (2002).

Helene, et al., “Control of gene expression by triple helix-forming oligonucleotides. The antigene strategy. ”, Ann, N. Y. Acad. Sci. 660: 27-36 (1992).

Hennenfent, et al., “Novel formulations of taxanes: a review. Old wine in a new bottle”, Ann Oncol., 17: 735-49 (2005).

Hermann and Patel, “Adaptive recognition by nucleic acid aptam­ers, ” Science, 287: 820-825 (2000).

Hieda, et al., “Active Immunization Alters the Plasma Nicotine Concentration in Rats”, J. Pharmacol. Exp. Therapeutics, 283: 1076­1081 (1997).

Hieda, et al., “Immunization of rats reduces nicotine distribution to brain”, Psychopharmacology, 143: 150-157 (1999).

Horoszewicz, et al., “Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients. ”, Anticancer Res., 7(5B): 927-935 (1987).

Hotter, et al., “Targeting of a B7-1 (CD80) immunoglobulin G fusion protein to acute myeloid leukemia blasts increases their costimulatory activity for autologous remission T cells. ”, Blood, 97(10): 3138-3145 (2001).

Houghton, “General method for the rapid solid-phase synthesis of large numbers of peptides: Specificity of antigen-antibody interac­tion at the level of individual amino acids”, Immunol., 82: 5131­5135 (1985).

Huang et al., “Microencapsulation of Chlorpheniramine Maleate- Resin Particles with Crosslinked Chitosan for Sustained Release”, Pharmaceutical Development and Technology, 4 1: 107-115 (1999). Helene, “The anti-gene strategy: control of gene expression by triplex-forming-oligonucleotides. ”, Anticancer Drug Des. 6(6): 569­584 (1991).

Jackson, et al., “Design and pharmacological activity of phosphinic acid based NAALADase inhibitors. ”, J. Med. Chem., 44(24): 4170- 4175 (2001).

Jackson, et al., “Design of NAALADase inhibitors: a novel neuroprotective strategy. ”, Curr. Med. Chem., 8(8): 949-957 (2001). Janes et al., “Chitosan nanoparticles as delivery systems for doxorubicin”, Journal of Controlled Release, 73: 255-267 (2001).

Jayaprakash, et al., “Design and synthesis of a PSMA inhibitor- doxorubicin conjugate for targeted prostate cancer therapy”, Chem Med Chem., 1: 299-302 (2006).

Jayasena, “Aptamers: An Emerging Class of Molecules That Rival Antibodies in Diagnostics”, Clinical Chemistry, 45(9): 1628-1650 (1999).

Johnson and Prud\Homme, “Mechanism for rapid self-assembly of block copolymer nanoparticles. ”, Phys. Rev. Lett., 91(11): 118302 (2003).

Jones and Leroux, “Polymeric micelles a new generation of colloi­dal drug carriers”, Eur. J. Pharmaceutics Biopharmaceutics, 48: 101- III (1999).

Jung, et al., “Tetanus Toxoid Loaded Nanoparticles from Sulfobutylated Poly(Vinyl Alcohol)-Graft-Poly(Lactide-co- Glycolide): Evaluation of Antibody Response After Oral and Nasal Application in Mice”, Pharmaceutical Research, 18(3): 352-360 (2001).

Junt, et al., “Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral В cells”, Nature, 450: 110-116 (2007).

Kabanov, et al., “DNA Complexes with Polycations for the Delivery of Genetic Material into Cells”, Bioconjugate Chem., 6(l): 7-20 (1995).

Kamentsky, “Laser scanning cytometry. ”, Methods Cell Biol., 63: 51-87 (2001).

Kanashiro, et al., “Inhibition of mutant p53 expression and growth of DMS-153 small cell lung carcinoma by antagonists of growth hormone-releasing hormone and bombesin. ”, Proc. Natl. Acad. Sci., USA, 100(26): 15836-15841 (2003).

Karlin and Altschul, “Applications and statistics for multiple high- scoring segments in molecular sequences. ”, Proc. Natl Acad. Sci. USA, 90(12): 5873-5877 (1993).

Karlin and Altschul, “Methods for assessing the statistical signifi­cance of molecular sequence features by using general scoring schemes. ”, Proc. Natl Acad Sci. USA, 87: 2264-2268 (1990).

Karrer, et al., “On the key role of secondary lymphoid organs in antiviral immune responses studied in alymphoplastic (aly/aly) and spleenless (Hoxll(-)/-) mutant mice. ”, J. Exp. Med., 185(12): 2157-2170 (1997).

Kawamura, et al., “Dendritic cells that endocytosed antigen-con­taining IgG-liposomes elicit effective antitumor immunity”, J Immunother., 29(2): 165-74 (2006).

Kawashima, et al., “Mucoadhesive DL-Lactide/Glycolide Copoly­mer Nanoshperes Coated with Chitosan to Improve Oral Delivery of Elcatonin”, Pharmaceutical Development and Technology, 5(1): 77- 85 (2000).

Kelly, et al., “The Optical Properties of Metal Nanoparticles: The Influence of Size, Shape, and Dielectric Environment”, J. Phys. Chem. B., 107(3): 668-677 (2003).

Khademhosseini, et al., “Cell docking inside microwells within reversibly sealed microfluidic channels for fabricating multiphenotype cell arrays, ” Lab Chip, 5(12): 1380-6 (2005).

© helpiks.su При использовании или копировании материалов прямая ссылка на сайт обязательна.